You have access
Loss of Heterozygosity of BRCA1/2 as a Predictive Marker for Talazoparib Response
AVITAL GRANIT MIZRAHI, HANEEN HAMAD, AHINOAM GUGENHEIM, BENJAMIN NISMAN, ANNA KUZNETZ, INNA BEN DAVID, YAEL GELFEND, SHERRI COHEN, AVIAD ZICK, KIM SHEVA, HOVAV NECHUSHTAN, TAMAR PERETZ and AMICHAY MEIROVITZ
Anticancer Research November 2022, 42 (11) 5257-5263; DOI: https://doi.org/10.21873/anticanres.16032